RM
Robert E Miller

Robert E Miller insider trades: Sonoma Pharmaceuticals (SNOA) stock purchases

Sonoma Pharmaceuticals Last trade Mar 13, 2018 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2009
2
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 13, 2018SNOA↑ Buy$10K
Mar 12, 2018SNOA↑ Buy$10K
Nov 29, 2017SNOA↑ Buy$9K
Nov 21, 2017SNOA↑ Buy$10K
Aug 10, 2017SNOA↑ Buy$12K
Mar 9, 2017SNOA↑ Buy$5K
Mar 8, 2017SNOA↑ Buy$7K
Dec 8, 2016SNOA↑ Buy$24K
Nov 11, 2009OCLS↑ Buy$22K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert E Miller's insider trades

Robert E Miller is an insider at Sonoma Pharmaceuticals (SNOA). Since Nov 11, 2009, Robert has reported 9 open-market purchases worth $109K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (15 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNOA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.